Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/32396
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCavalheiro, Sergio [UNIFESP]
dc.contributor.authorDi Rocco, Concezzio
dc.contributor.authorValenzuela, Sergio
dc.contributor.authorDastoli, Patricia A. [UNIFESP]
dc.contributor.authorTamburrini, Gianpiero
dc.contributor.authorMassimi, Lucca
dc.contributor.authorNicacio, Jardel M. [UNIFESP]
dc.contributor.authorFaquini, Igor V. [UNIFESP]
dc.contributor.authorIerardi, Daniela F. [UNIFESP]
dc.contributor.authorSilva, Nasjla Saba [UNIFESP]
dc.contributor.authorPettorini, Benedetta Ludovica
dc.contributor.authorToledo, Silvia Regina Caminada de [UNIFESP]
dc.date.accessioned2016-01-24T13:59:29Z-
dc.date.available2016-01-24T13:59:29Z-
dc.date.issued2010-04-01
dc.identifierhttp://dx.doi.org/10.3171/2010.1.FOCUS09310
dc.identifier.citationNeurosurgical Focus. Rolling Meadows: Amer Assoc Neurological Surgeons, v. 28, n. 4, 5 p., 2010.
dc.identifier.issn1092-0684
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/32396-
dc.description.abstractObject. the authors assessed the efficacy of intratumoral interferon-alpha (IFN alpha)-based chemotherapy in pediatric patients with cystic craniopharyngiomas.Methods. in a prospective multicenter study of 60 pediatric patients, the authors assessed the efficacy of intratumoral INF alpha 2A-based chemotherapy. the study was conducted between 2000 and 2009 at 3 locations: the Medical School of the Federal University of São Paulo, Catholic University of Rome, and the Neurosurgery Institute of Santiago, Chile. the assessment included clinical and radiological control examinations, side effects observed, and total dose used.Results. Sixty cases of cystic craniopharyngioma were analyzed. the cohort consisted of 35 male and 25 female children (mean age 11 years). Clinical and radiological improvement was achieved in 76% of the cases. New endocrinological deficits were observed in 13% of the cases. in approximately 30% of the patients, the evolution included some light side effects, the most common being headache (33%) and eyelid edema (28%). the number of cycles varied from 1 to 9 (mean 5 cycles), and the total dose applied per cycle was 36,000,000 IU.Conclusions. This has been the largest documented series of intratumoral chemotherapy using INF alpha for the control of cystic craniopharyngiomas. the treatment has proved efficacious; there was no mortality, and morbidity rates were low. (DOI: 10.3171/2010.1.FOCUS09310)en
dc.format.extent5
dc.language.isoeng
dc.publisherAmer Assoc Neurological Surgeons
dc.relation.ispartofNeurosurgical Focus
dc.rightsAcesso aberto
dc.subjectcraniopharyngiomaen
dc.subjectinterferon-alphaen
dc.subjecthypothalamusen
dc.subjectobesityen
dc.subjectdiabetes insipidusen
dc.titleCraniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 casesen
dc.typeArtigo
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUniv Cattolica Sacro Cuore
dc.contributor.institutionNeurosurg Inst Santiago
dc.contributor.institutionPoliclin Gemelli
dc.description.affiliationUniversidade Federal de São Paulo, Dept Neurosurg, São Paulo, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, Sect Pediat Neurosurg, São Paulo, Brazil
dc.description.affiliationUniv Cattolica Sacro Cuore, Dept Neurosurg, Rome, Italy
dc.description.affiliationNeurosurg Inst Santiago, Dept Neurosurg, Santiago, Chile
dc.description.affiliationPoliclin Gemelli, Dept Neurosurg, Sect Pediat Neurosurg, Rome, Italy
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Neurosurg, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Sect Pediat Neurosurg, São Paulo, Brazil
dc.identifier.doi10.3171/2010.1.FOCUS09310
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000276212900015
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.